Do Pretransplant C-Peptide Levels Influence Outcomes in Simultaneous Kidney-Pancreas Transplantation?

Transplantation Proceedings

Volumn 40, Issue 2, 2008, Pages 510-512

  Singh, R P ^a   Rogers, J ^a   Farney, A C ^a   Hartmann, E L ^a   Reeves Daniel, A ^a   Doares, W ^a   Ashcraft, E ^a   Adams, P L ^a   Stratta, R J ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CREATININE; HEMOGLOBIN A1C;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; COURSE EVALUATION; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT INFECTION; GRAFT RECIPIENT; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION;

ADULT; AGE OF ONSET; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PANCREAS TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 40949147020     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.01.048     Document Type: Article

References (7)

1. Nath D., Gruessner A., Kandaswamy R., et al. Outcomes of pancreas transplants for patients with type 2 diabetes mellitus. Clin Transplant 19 (2005) 792
2. Light J., Sasaki T., Currier C., et al. Successful long-term kidney-pancreas transplants regardless of C-peptide status or race. Transplantation 71 (2001) 152
3. Light J., and Barhyte D. Simultaneous pancreas-kidney transplants in type I and type II diabetic patients with end-stage renal disease: similar 10-year outcomes. Transplant Proc 37 (2005) 1283
4. Gruessner A., and Sutherland D. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 19 (2005) 433
5. Gjessing H.J., Matzen L.E., Faber O.K., et al. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 32 (1989) 305
6. Manzanares J., Conget I., Gonzalez-Clemente J., et al. Insulin treatment in diabetes mellitus type II: the usefulness of the breakfast test. Med Clin (Barc) 104 (1995) 761
7. Esmatjes E., Fernández C., Rueda S., et al. The utility of the C-peptide in the phenotyping of patient candidates for pancreas transplantation. Clin Transplant 21 (2007) 358